tiprankstipranks
Sera Prognostics’ PreTRM Test Faces Regulatory Risks: The Financial Implications of Potential FDA Hurdles
PremiumCompany AnnouncementsSera Prognostics’ PreTRM Test Faces Regulatory Risks: The Financial Implications of Potential FDA Hurdles
4M ago
Sera Prognostics Unveils New Investor Presentation Update
PremiumCompany Announcements
Sera Prognostics Unveils New Investor Presentation Update
4M ago
SERA PROGNOSTICS REPORTS FOURTH QUARTER 2023 FINANCIAL RESULTS
PremiumPress Releases
SERA PROGNOSTICS REPORTS FOURTH QUARTER 2023 FINANCIAL RESULTS
4M ago
SERA PROGNOSTICS REPORTS THIRD QUARTER 2023 FINANCIAL RESULTS
PremiumPress ReleasesSERA PROGNOSTICS REPORTS THIRD QUARTER 2023 FINANCIAL RESULTS
8M ago
Sera Prognostics reports Q2 EPS (34c), consensus (36c)
PremiumThe Fly
Sera Prognostics reports Q2 EPS (34c), consensus (36c)
11M ago
SERA PROGNOSTICS REPORTS SECOND QUARTER 2023 FINANCIAL RESULTS
PremiumPress Releases
SERA PROGNOSTICS REPORTS SECOND QUARTER 2023 FINANCIAL RESULTS
11M ago
Sera Prognostics’ PreTRM test shows predictive efficacy in Avert trial
PremiumThe FlySera Prognostics’ PreTRM test shows predictive efficacy in Avert trial
1y ago
SERA PROGNOSTICS REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS
PremiumPress Releases
SERA PROGNOSTICS REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS
2y ago
SERA PROGNOSTICS REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS
PremiumPress Releases
SERA PROGNOSTICS REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS
2y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100